SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile app in the United States on August 20, ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile ...
(Nasdaq: TNDM) a leading insulin delivery and diabetes technology company, today announced availability of the Tandem t:slim mobile application for Android and iOS users in Canada. The Tandem t:slim ...
The US Food and Drug Administration (FDA) has announced that Tandem Diabetes Care, Inc has issued a recall regarding version 2.7 of the Apple iOS t:connect mobile app that is used in conjunction with ...
Version 2.7 of the t:connect iOS app – which is used to control delivery of insulin by the t:slim X2 pump – has been urgently recalled by the FDA. The FDA issued a Class I recall, which is reserved ...
An IOS app used in conjunction with the t:slim X2 insulin pump with Control-IQ could be malfunctioning So far, there have been 224 reports of injuries occurring when the app drained the pump's battery ...
More than 200 people with diabetes were injured after technology defect caused their insulin pump to unexpectedly shut down, according to the Food and Drug Administration. The software glitch has ...
FDA recently identified Tandem Diabetes Care’s recall of its version 2.7 of the Apple iOS t:connect mobile app used in conjunction with the t:slim X2 insulin pump with Control -IQ technology as Class ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NewsNation) — The U.S. Food and Drug ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. The US Food and Drug Administration issued a software recall after a ...
Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
The recall notice, which the FDA says is a "correction" rather than a product removal. HealthDay News — The US Food and Drug Administration has issued a Class 1 recall — its most urgent kind — for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results